EASY-TO-USE, LIGHTWEIGHT, RAPID DIAGNOSTIC SOLUTIONS FOR BIODEFENSE

Rapid field identification of chemical, biological, radiological, and nuclear threats; emerging infectious diseases and pandemic influenza; and other agents.

Early detection of chemical, biological, radiological, and nuclear threats; infectious diseases; and other agents is critical for emergency preparedness and rapid response to bioterrorism. DCN Diagnostics’ engineers design lightweight, portable, easy-to-use diagnostic assays for emergency response teams, public health officers, law enforcement, and the military.

With rapid diagnostics from DCN Diagnostics, you can evaluate biomarkers and pathogen markers applicable to biothreats; monitor water and food supplies for contamination; and identify other chemical, biological, radiological, or nuclear threats in under 30 minutes without shipping samples to a laboratory and waiting for results.

SMALL, DURABLE RAPID DIAGNOSTICS ENGINEERED FOR FIELD USE

Three features make these rapid tests invaluable for biodefense teams and first responders:

  • Designed for use in the field: Our portable point-of-care diagnostics are small and lightweight, and let you test without shipping samples to a laboratory.
  • Easy to use: Minimize errors with easy-to-use sample collection and cartridge design developed for use in the field with minimal training.
  • Fast: Get results in under 30 minutes.

CONDUCT TESTS WITHOUT SHIPPING YOUR SAMPLE

When you use our rapid diagnostic tests, you eliminate the need to send a sample to an external laboratory for testing. Instead, the entire testing process can be completed in any field setting.

MINIMIZE ERRORS WITH OUR SIMPLE END-USER DESIGN

Minimize biodefense sample collection and other user errors with our rapid contaminant identification diagnostic tests engineered with the end user in mind. Minimal training is required and every rapid diagnostic test displays your results in a clear and straightforward output.

FAST RESULTS…NO LAB REQUIRED!

Get immediate results in the field without sending samples to the lab and waiting up to 5 days for results.

DCN Dx is globally recognized as the go-to company for contract development and commercialization of easy-to-use, rapid diagnostic tests. Our team of more than 30 seasoned assay development scientists bring unparalleled expertise to lateral flow and flow through immunoassay development. Internal design for manufacturing expertise ensures scalability and manufacturability of the final diagnostic product.

Get started today

CASE STUDY: QUANTITATIVE BIODOSIMETER ASSAY

DCN was contracted to develop a lightweight point-of-care biodosimeter unit engineered for robust field deployment and ease of use. The resulting multiplexed, two-step biodosimeter assay delivers highly accurate, specific results to determine radiation exposure.

  • Fully quantitative multiplex (4 proteins), 2-strip biomarker assay system with integrated whole blood sample collector (SC) and sample processing module. SC consist of preloaded buffer chamber and capillary. Cartridge contains test strips and MSS (mixer, RBC separator, sample splitter).
  • Results are available 30 minutes after the initiation of the assay. Analytical sensitivity of the different biomarkers ranges from ~120pg/mL (analyte M), 250pg/mL (F), 100ng/mL (AM), to 150ug/mL (AA), all well within the assay specification requirements.

CASE STUDY: MULTIPLEX FLUORESCENT ASSAY PLATFORM FOR INFECTIOUS DISEASE IDENTIFICATION

DCN was contracted to develop an easy-to-use, small 8-line multiplex infectious disease serology assay (7 antigens + control) for the detection of antibodies in human serum, plasma, whole blood, and dried blood spots.

  • Developed prototype cassette for multiplex test strip with 2 ports for the application of sample and buffer.
  • The prototype test correctly identified all 12 human samples and the various ferret serum samples provided to DCN by the client at the 20 minutes assay read time.

Contact us for more information about our experience developing rapid diagnostic tests for a variety of infectious diseases and chemical, biological, and nuclear threats.

Learn More